Rebecca Calder, DPM
Foot & Ankle Surgery · Beverly, MANPI 1538666557
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (37.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 61.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $2,799 and has fallen 96.8% since, to $89 in 2025.
Across 38 payments — averaging $87.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Kairos Surgical Inc$587
- Smith+Nephew$535
- Vertex$46
- Averitas Pharma Inc.$38
- Osteomed LLC$30
- plus $58 from 3 others
What the payments were for
- Travel & lodging$1,17035%
- Food & beverage$92028%
- Education$1,23037%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 13 | $2,025 |
| Kairos Surgical Inc | 3 | $587 |
| Smith+Nephew | 16 | $535 |
| Vertex | 1 | $46 |
| Averitas Pharma Inc. | 1 | $38 |
| Osteomed LLC | 1 | $30 |
| Medtronic | 1 | $25 |
| GSK | 1 | $18 |
| Voom Medical Devices, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GRAFIX PL$254
- Stravix$254
- Grafix$150
- STRAVIX PL$150
How this compares
$3,319 in reported general payments places this provider in the 65th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 28 | $670 |
| Betamethasone Dipropionate | 13 | $491 |
| Doxycycline Monohydrate | 36 | $343 |
| Ammonium Lactate | 15 | $227 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $172 |
| Cephalexin | 14 | $105 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Beverly
- Harry SchneiderCambridge$174K
- Craig LareauSpringfield$115K
- David SipalaBrighton$94K
- Philip BasileCambridge$90K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
- Richard BakerHyannis$16K
- Mark SlovenkaiWaltham$14K
- Jaeyoung KimBoston$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.